Multiple Additions to the Prescription Drug List (PDL)
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNovavax COVID-19 vaccine
On February 17, 2022, Health Canada authorized the sixth vaccine in Canada for the prevention of COVID-19. Learn more about the Novavax Nuvaxovid COVID-19 protein subunit vaccine.
View ArticleMedicago Covifenz COVID-19 vaccine
On February 24, 2022, Health Canada authorized the seventh vaccine in Canada for the prevention of COVID-19. Learn more about the Medicago Covifenz COVID-19 plant-based vaccine.
View ArticleNotice: Regulations amending certain regulations concerning drugs and medical...
The Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) were made on 03-02, 2022. They amend the Food and Drug Regulations and Medical Devices Regulations that...
View ArticleNotice: Period reduced for keeping clinical trial records for drugs and...
Information on Health Canada reducing the period for keeping clinical trial records for drugs and natural health products from 25 years to 15 years.
View ArticleNotice of updated guidance: Applications for COVID-19 drug clinical trials...
Health Canada has updated and renamed the guidance document that was created for the interim orders No. 1 and No. 2 for COVID-19-related clinical trials for drugs.
View ArticleNotice: Clinical trials for medical devices and drugs relating to COVID-19...
Information on the regulations for clinical trials for medical devices and drugs relating to COVID-19 transition from the Interim Order.
View ArticleNotice of Amendment: Tramadol removed from the Prescription Drug List (PDL)
Documents to announce the removal of tramadol to the Prescription Drug List.
View ArticleKeeping Health Products In Canada Safe
Defines what health products are and how Health Canada continues to monitor them after authorization to ensure they are safe, effective and of high quality.
View ArticleAuthorization of Evusheld COVID-19 treatment
On April 14, 2022, Health Canada authorized the Evusheld treatment in Canada for the prevention of COVID-19. Learn more about the treatment.
View ArticleRemdesivir is now approved for treating COVID-19 in an outpatient setting
On April 22, 2022, Health Canada authorized remdesivir for the treatment of COVID-19 in an outpatient setting. When administered within 7 days of symptoms appearing, remdesivir was demonstrated to...
View ArticleNotice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL)
Documents to announce the revision of brimonidine on the Prescription Drug List.
View ArticleNotice: Multiple additions to the Prescription Drug List (PDL)
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice of Intent to Amend the Prescription Drug List (PDL): Betaine
Notice of Intent to Amend the Prescription Drug List (PDL) for Betaine.
View ArticleNotice of Amendment: Addition of Metamizole (Dipyrone) to the Prescription...
Documents to announce the Notice of Amendment to add metamizole (dipyrone) to the PDL.
View ArticleNotice: Multiple Additions to the Prescription Drug List (PDL)
Documents to announce multiple updates to the Prescription Drug List.
View ArticleAuthorization of Actemra COVID-19 treatment
On October 13, 2022, Health Canada authorized the use of Actemra as a treatment for adults with severe COVID-19 who are in hospital.
View ArticleAuthorization of Evusheld COVID-19 expanded indication
On October 18, 2022, Health Canada authorized the expanded use of Evusheld as a treatment for adults and adolescents over 12 with mild to moderate COVID-19 symptoms.
View ArticleUpdates to the Guidance on amendments to the Food and Drug Regulations for...
Health Canada has updated our Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19.
View ArticleConsultation on proposed agile regulations and guidance for licensing drugs...
Health Canada is proposing new targeted provisions and regulatory amendments to the Food and Drug Regulations and Medical Devices Regulations. These changes will continue to advance our modernization...
View Article
